Judge Orders 2 More Bellwethers In Fosamax MDL

Merck & Co. will help select two additional bellwether cases for trial in a multidistrict litigation over its osteoporosis drug Fosamax following a federal judge's ruling that a couple of key...

Already a subscriber? Click here to view full article